{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:46:06Z","timestamp":1782906366895,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00277-018-3383-9","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:35:00Z","timestamp":1528158900000},"page":"1987-1994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study"],"prefix":"10.1007","volume":"97","author":[{"given":"Ioanna","family":"Sakellari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8883-8208","authenticated-orcid":false,"given":"Eleni","family":"Gavriilaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Chatziioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Mallouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Batsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Bousiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Bouziana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varnavas","family":"Constantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Douka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysa","family":"Apostolou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Iskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysavgi","family":"Lalayanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Athanasiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damianos","family":"Sotiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Yannaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Gianouzakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilles","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"issue":"4","key":"3383_CR1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","volume":"49","author":"ED Thomas","year":"1977","unstructured":"Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49(4):511\u2013533","journal-title":"Blood"},{"issue":"12","key":"3383_CR2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.exphem.2003.09.008","volume":"31","author":"C Ferry","year":"2003","unstructured":"Ferry C, Socie G (2003) Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned? Exp Hematol 31(12):1182\u20131186","journal-title":"Exp Hematol"},{"issue":"9","key":"3383_CR3","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","volume":"83","author":"O Ringden","year":"1994","unstructured":"Ringden O, Ruutu T, Remberger M, Nikoskelainen J, Volin L, Vindelov L et al (1994) A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 83(9):2723\u20132730","journal-title":"Blood"},{"issue":"6","key":"3383_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.bmt.1704198","volume":"32","author":"N Bunin","year":"2003","unstructured":"Bunin N, Aplenc R, Kamani N, Shaw K, Cnaan A, Simms S (2003) Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant 32(6):543\u2013548. https:\/\/doi.org\/10.1038\/sj.bmt.1704198","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"3383_CR5","first-page":"1060","volume":"85","author":"E Granados","year":"2000","unstructured":"Granados E, de La Camara R, Madero L, Diaz MA, Martin-Regueira P, Steegmann JL et al (2000) Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation. Haematologica 85(10):1060\u20131067","journal-title":"Haematologica"},{"issue":"22","key":"3383_CR6","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJM198312013092202.","volume":"309","author":"GW Santos","year":"1983","unstructured":"Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H, Mellits D, Sensenbrenner LL, Stuart RK, Yeager AM (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 309(22):1347\u20131353. https:\/\/doi.org\/10.1056\/NEJM198312013092202.","journal-title":"N Engl J Med"},{"issue":"5","key":"3383_CR7","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","volume":"70","author":"PJ Tutschka","year":"1987","unstructured":"Tutschka PJ, Copelan EA, Klein JP (1987) Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70(5):1382\u20131388","journal-title":"Blood"},{"issue":"9","key":"3383_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1053\/bbmt.2002.v8.pm12374454","volume":"8","author":"A Kashyap","year":"2002","unstructured":"Kashyap A, Wingard J, Cagnoni P, Roy J, Tarantolo S, Hu W et al (2002) Intravenous versus oral busulfan as part of a busulfan\/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality. Biol Blood Marrow Transplant 8(9):493\u2013500","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"3383_CR9","first-page":"285","volume":"90","author":"SE Kim","year":"2005","unstructured":"Kim SE, Lee JH, Choi SJ, Ryu SG, Lee KH (2005) Morbidity and non-relapse mortality after allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan. Haematologica 90(2):285\u2013286","journal-title":"Haematologica"},{"issue":"3","key":"3383_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/bbmt.2002.v8.pm11939604","volume":"8","author":"BS Andersson","year":"2002","unstructured":"Andersson BS, Kashyap A, Gian V, Wingard JR, Fernandez H, Cagnoni PJ, Jones RB, Tarantolo S, Hu WW, Blume KG, Forman SJ, Champlin RE (2002) Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study. Biol Blood Marrow Transplant 8(3):145\u2013154","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"3383_CR11","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.bmt.1700994","volume":"20","author":"P Ljungman","year":"1997","unstructured":"Ljungman P, Hassan M, Bekassy AN, Ringden O, Oberg G (1997) High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients. Bone Marrow Transplant 20(11):909\u2013913. https:\/\/doi.org\/10.1038\/sj.bmt.1700994","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"3383_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/10428190903419130","volume":"51","author":"X Shi-Xia","year":"2010","unstructured":"Shi-Xia X, Xian-Hua T, Hai-Qin X, Bo F, Xiang-Feng T (2010) Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis. Leuk Lymphoma 51(1):50\u201360. https:\/\/doi.org\/10.3109\/10428190903419130","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"3383_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bbmt.2011.04.003.","volume":"17","author":"W Tang","year":"2011","unstructured":"Tang W, Wang L, Zhao WL, Chen YB, Shen ZX, Hu J (2011) Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 17(10):1555\u20131561. https:\/\/doi.org\/10.1016\/j.bbmt.2011.04.003.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"3383_CR14","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.bbmt.2016.09.007.","volume":"22","author":"K Mitsuhashi","year":"2016","unstructured":"Mitsuhashi K, Kako S, Shigematsu A, Atsuta Y, Doki N, Fukuda T, Kanamori H, Onizuka M, Takahashi S, Ozawa Y, Kurokawa M, Inoue Y, Nagamura-Inoue T, Morishima Y, Mizuta S, Tanaka J, Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (2016) Comparison of cyclophosphamide combined with total body irradiation, oral busulfan, or intravenous busulfan for allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 22(12):2194\u20132200. https:\/\/doi.org\/10.1016\/j.bbmt.2016.09.007.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3383_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbmt.2017.11.025.","volume":"24","author":"P Kebriaei","year":"2017","unstructured":"Kebriaei P, Anasetti C, Zhang MJ, Wang HL, Aldoss I, de Lima M, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea S, Lazarus HM, Gale RP, Litzow M, Bredeson C, Seftel MD, Pulsipher MA, Boelens JJ, Alvarnas J, Champlin R, Forman S, Pullarkat V, Weisdorf D, Marks DI, Hogan W, Battiwalla M, Copelan E, Hildebrandt G, Ganguly S, Majhail N, Woolfrey A, Nivison-Smith I, Hertzberg M, Diaz MA, Jakubowski A, Ustun C, Yong A, Freytes C, DeFilipp Z, Inamoto Y, Cahn JY, Savani B, Yared J, Bajel A, Bacher U, Uy G, Rizzieri D, Wieduwilt M, Schultz K, Grunwald M, Kamble R, Qayed M, Brammer J, Ballen K, Khera N, Schouten H, Bierings M, Kanakry C, Wood WA, Saad A, Savoie L, Hamilton BK, Aljurf M, Vij R, Pawarode A, Olsson R, Wirk BM, Beitinjaneh A, Seo S, Cerny J, Akpek G, Norkin M, Nishihori T, Lazaryan A, Sabloff M (2017) Intravenous busulfan compared with total body irradiation pretransplant conditioning for adults with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 24:726\u2013733. https:\/\/doi.org\/10.1016\/j.bbmt.2017.11.025.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"3383_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/ajh.24823.","volume":"92","author":"S Eder","year":"2017","unstructured":"Eder S, Canaani J, Beohou E, Labopin M, Sanz J, Arcese W, Or R, Finke J, Cortelezzi A, Beelen D, Passweg J, Soci\u00e9 G, Gurman G, Aljurf M, Stelljes M, Giebel S, Mohty M, Nagler A (2017) Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: a matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Am J Hematol 92(10):997\u20131003. https:\/\/doi.org\/10.1002\/ajh.24823.","journal-title":"Am J Hematol"},{"key":"3383_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.blre.2017.09.005","volume":"32","author":"BD Friend","year":"2017","unstructured":"Friend BD, Schiller GJ (2017) Closing the gap: novel therapies in treating acute lymphoblastic leukemia in adolescents and young adults. Blood Rev 32:122\u2013129. https:\/\/doi.org\/10.1016\/j.blre.2017.09.005","journal-title":"Blood Rev"},{"issue":"6","key":"3383_CR18","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15(6):825\u2013828","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"3383_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0889-8588(05)70111-8","volume":"13","author":"ME Flowers","year":"1999","unstructured":"Flowers ME, Kansu E, Sullivan KM (1999) Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 13(5):1091\u20131112 viii-ix","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10","key":"3383_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.clml.2017.06.008","volume":"17","author":"I Sakellari","year":"2017","unstructured":"Sakellari I, Batsis I, Bousiou Z, Mallouri D, Constantinou V, Gavriilaki E, Smias C, Yannaki E, Kaloyannidis P, Papaioannou G, Stavroyianni N, Syrigou A, Sotiropoulos D, Fylaktou A, Tsompanakou A, Saloum R, Anagnostopoulos A (2017) The role of low-dose anti-thymocyte globulin as standard prophylaxis in mismatched and matched unrelated hematopoietic peripheral stem cell transplantation for hematologic malignancies. Clin Lymphoma Myeloma Leuk 17(10):658\u2013666. https:\/\/doi.org\/10.1016\/j.clml.2017.06.008","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"3383_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48(3):452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"3383_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/sj.bmt.1701334","volume":"22","author":"AR Hartman","year":"1998","unstructured":"Hartman AR, Williams SF, Dillon JJ (1998) Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan\/cyclophosphamide vs total body irradiation: a meta-analysis. Bone Marrow Transplant 22(5):439\u2013443. https:\/\/doi.org\/10.1038\/sj.bmt.1701334","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"3383_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1179\/1607845414Y.0000000175","volume":"20","author":"YY Hwang","year":"2015","unstructured":"Hwang YY, Mohty M, Chim CS (2015) Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond. Hematology 20(2):61\u201371. https:\/\/doi.org\/10.1179\/1607845414Y.0000000175","journal-title":"Hematology"},{"issue":"1","key":"3383_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3324\/haematol.2016.145631","volume":"102","author":"S Giebel","year":"2017","unstructured":"Giebel S, Labopin M, Socie G, Beelen D, Browne P, Volin L et al (2017) Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica 102(1):139\u2013149. https:\/\/doi.org\/10.3324\/haematol.2016.145631","journal-title":"Haematologica"},{"issue":"1","key":"3383_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","volume":"119","author":"M Jagasia","year":"2012","unstructured":"Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS et al (2012) Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 119(1):296\u2013307. https:\/\/doi.org\/10.1182\/blood-2011-06-364265","journal-title":"Blood"},{"issue":"4","key":"3383_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/bmt.2014.293","volume":"50","author":"H Nakasone","year":"2015","unstructured":"Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T et al (2015) Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation. Bone Marrow Transplant 50(4):559\u2013565. https:\/\/doi.org\/10.1038\/bmt.2014.293","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3383_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1399-0012.2007.00664.x","volume":"21","author":"YH Cho","year":"2007","unstructured":"Cho YH, Lim HA, Lee MH, Kim I, Lee JS, Park S et al (2007) Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation. Clin Transpl 21(3):417\u2013422. https:\/\/doi.org\/10.1111\/j.1399-0012.2007.00664.x","journal-title":"Clin Transpl"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3383-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3383-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3383-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T22:27:17Z","timestamp":1571437637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3383-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["3383"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3383-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}